Exact Mass: 364.9793

Exact Mass Matches: 364.9793

Found 35 metabolites which its exact mass value is equals to given mass value 364.9793, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Nifursol

2-Hydroxy-3,5-dinitro-N-[(1Z)-(5-nitrofuran-2-yl)methylidene]benzene-1-carbohydrazonate

C12H7N5O9 (365.0244)


Veterinary antiprotozoal, especially for poultr

   
   

3-(3,5-dibromo-4-methoxyphenyl)-2-methoxy-N-methylpropan-1-amine

3-(3,5-dibromo-4-methoxyphenyl)-2-methoxy-N-methylpropan-1-amine

C12H17Br2NO2 (364.9626)


   

YK-4-279

4,7-dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2H-indole-2-one

C17H13Cl2NO4 (365.0222)


   
   

Nifursol

2-Hydroxy-3,5-dinitrobenzoic acid [(5-nitro-2-furanyl)methylene]hydrazide, 9ci

C12H7N5O9 (365.0244)


C254 - Anti-Infective Agent > C258 - Antibiotic

   

2,7-dibromo-9,9-dimethylacridan

2,7-dibromo-9,9-dimethylacridan

C15H13Br2N (364.9415)


   

1-chloro-N-(2-(ethylsulfonyl)-5-(trifluoromethyl)phenyl)methanesulfonamide

1-chloro-N-(2-(ethylsulfonyl)-5-(trifluoromethyl)phenyl)methanesulfonamide

C10H11ClF3NO4S2 (364.977)


   

2-BENZYLOXY-6-FLUOROPHENYLBORONIC ACID

2-BENZYLOXY-6-FLUOROPHENYLBORONIC ACID

C11H14BClINO2 (364.9851)


   

Glucantime

Meglumine antimonate

C7H18NO8Sb (365.0071)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CB - Antimony compounds D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents

   

Bis(4-nitrophenyl) phosphorazidate

Bis(4-nitrophenyl) phosphorazidate

C12H8N5O7P (365.0161)


   

N-(4-benzoylphenyl)-2-iodoacetamide

N-(4-benzoylphenyl)-2-iodoacetamide

C15H12INO2 (364.9913)


   

5-(6-Bromonaphthalen-2-yl)-2,2-dimethyl-5-nitro-1,3-dioxane

5-(6-Bromonaphthalen-2-yl)-2,2-dimethyl-5-nitro-1,3-dioxane

C16H16BrNO4 (365.0263)


   

6-BROMO-5-(2-FLUORO-4-NITROPHENOXY)-1-METHYL-1H-INDAZOLE

6-BROMO-5-(2-FLUORO-4-NITROPHENOXY)-1-METHYL-1H-INDAZOLE

C14H9BrFN3O3 (364.9811)


   

3-ETHYL-2-METHYL-5-PHENYL-BENZOOXAZOL-3-IUM IODIDE

3-ETHYL-2-METHYL-5-PHENYL-BENZOOXAZOL-3-IUM IODIDE

C16H16INO (365.0277)


   

Bis(trifluoro-2,4-pentanedionato)cobalt(II) Hydrate

Bis(trifluoro-2,4-pentanedionato)cobalt(II) Hydrate

C10H8CoF6O4 (364.9659)


   

Brocrinat

Brocrinat

C15H9BrFNO4 (364.9699)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic

   

3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)-N-METHOXY-N-METHYLTHIOPHENE-2-CARBOXAMIDE

3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)-N-METHOXY-N-METHYLTHIOPHENE-2-CARBOXAMIDE

C11H12ClN3O5S2 (364.9907)


   

3-(2-CHLORO-6-FLUOROPHENYL)-N-(2-CHLORO-3-PYRIDINYL)-5-METHYL-4-ISOXAZOLECARBOXAMIDE

3-(2-CHLORO-6-FLUOROPHENYL)-N-(2-CHLORO-3-PYRIDINYL)-5-METHYL-4-ISOXAZOLECARBOXAMIDE

C16H10Cl2FN3O2 (365.0134)


   

POLYSTYRENE SUPPORTED IODOBENZENE DIACETATE

POLYSTYRENE SUPPORTED IODOBENZENE DIACETATE

C12H16INO4 (365.0124)


   

6-Chloro-3-indolyl β-D-glucuronide sodium salt

6-Chloro-3-indolyl β-D-glucuronide sodium salt

C14H13ClNNaO7 (365.0278)


   

6-bromo-2-chloro-3-[(4-chlorophenyl)methyl]quinoline

6-bromo-2-chloro-3-[(4-chlorophenyl)methyl]quinoline

C16H10BrCl2N (364.9374)


   
   

2-({[4-(Trifluoromethoxy)phenyl]sulfonyl}amino)ethyl Dihydrogen Phosphate

2-({[4-(Trifluoromethoxy)phenyl]sulfonyl}amino)ethyl Dihydrogen Phosphate

C9H11F3NO7PS (364.9946)


   

Orotidine 5-phosphate(3-)

Orotidine 5-phosphate(3-)

C10H10N2O11P-3 (365.0022)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

acetamidomethyl-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxyphosphinic acid

acetamidomethyl-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxyphosphinic acid

C8H17NO11P2 (365.0277)


   

1-[4-(4-Bromophenyl)-2-thiazolyl]-4-piperidinecarboxamide

1-[4-(4-Bromophenyl)-2-thiazolyl]-4-piperidinecarboxamide

C15H16BrN3OS (365.0197)


   

1-(3,4-Dichlorophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea

1-(3,4-Dichlorophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea

C14H9Cl2N5OS (364.9905)


   

3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide

3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide

C12H10F3N3O3S2 (365.0116)


   

4-[(E)-(5-bromothiophen-2-yl)methylideneamino]-3-pyridin-2-yl-1H-1,2,4-triazole-5-thione

4-[(E)-(5-bromothiophen-2-yl)methylideneamino]-3-pyridin-2-yl-1H-1,2,4-triazole-5-thione

C12H8BrN5S2 (364.9404)


   

Methyl 2-O-chlorobenzoyl-4-chloro-N-methyloxalonilate

Methyl 2-O-chlorobenzoyl-4-chloro-N-methyloxalonilate

C17H13Cl2NO4 (365.0222)


   

Orotidine 5-phosphate(3-)

Orotidine 5-phosphate(3-)

C10H10N2O11P (365.0022)


Trianion of orotidine 5-phosphate arising from deprotonation of carboxylic acid and phosphate functions.

   

BMS-986121

BMS-986121

C15H9Cl2N3O2S (364.9793)


BMS-986121 is a positive allosteric modulator (PAM) of the μ opioid receptor extracted from patent WO2014107344. BMS-986121 is built on a chemical scaffold representing a new chemotype for μ receptor PAMs[1][2][3].

   

5-bromo-1-[1-(methylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

5-bromo-1-[1-(methylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

C15H16BrN3OS (365.0197)


   

5-bromo-1-[(1s)-1-(methylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

5-bromo-1-[(1s)-1-(methylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

C15H16BrN3OS (365.0197)